Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of ORIC Pharmaceuticals Inc (NASDAQ: ORIC) was $13.16 for the day, down -5.39% from the previous closing price of $13.91. In other words, the price has decreased by -$5.39 from its previous closing price. On the day, 1.49 million shares were traded. ORIC stock price reached its highest trading level at $13.78 during the session, while it also had its lowest trading level at $13.16.
Ratios:
Our analysis of ORIC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 16.13 and its Current Ratio is at 16.13. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 08, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $15.
On October 31, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.Wells Fargo initiated its Overweight rating on October 31, 2024, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 06 ’25 when Piscitelli Dominic sold 11,000 shares for $14.52 per share. The transaction valued at 159,719 led to the insider holds 48,317 shares of the business.
Chacko Jacob sold 37,461 shares of ORIC for $461,520 on Oct 06 ’25. The PRESIDENT AND CEO now owns 531,419 shares after completing the transaction at $12.32 per share. On Oct 06 ’25, another insider, Dominic Piscitelli, who serves as the Officer of the company, bought 50,000 shares for $14.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 1352008064 and an Enterprise Value of 1003710528.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.62, which has changed by 0.36373055 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.93, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is 20.88%, while the 200-Day Moving Average is calculated to be 47.93%.
Shares Statistics:
ORIC traded an average of 1.25M shares per day over the past three months and 1782840 shares per day over the past ten days. A total of 86.19M shares are outstanding, with a floating share count of 56.09M. Insiders hold about 42.25% of the company’s shares, while institutions hold 63.04% stake in the company. Shares short for ORIC as of 1759190400 were 11242529 with a Short Ratio of 8.98, compared to 1756425600 on 8174386. Therefore, it implies a Short% of Shares Outstanding of 11242529 and a Short% of Float of 11.72.
Earnings Estimates
Currently, 11.0 analysts are dedicated to thoroughly evaluating and rating the performance of ORIC Pharmaceuticals Inc (ORIC) in the stock market.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.29 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.29 and -$2.53 for the fiscal current year, implying an average EPS of -$1.71. EPS for the following year is -$1.71, with 11.0 analysts recommending between -$1.03 and -$2.84.
